—

SPDR® S&P Biotech ETF (XBI) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +0.1% vs the 50-day and +8.8% vs the 200-day average, 8.7% below the 52-week high and +46.4% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: SPDR® S&P Biotech ETF trades 0.1% above its 50-day and 8.8% above its 200-day moving average. (as of 2026-11-10)

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the XBI overview. Research diary readings, not advice.

Uptrend stack intact

Trades +0.1% vs the 50-day and +8.8% vs the 200-day average, 8.7% below the 52-week high and +46.4% off the 52-week low. Computed from daily closes.

Ranked #4 on today’s Directional Flow — theme flow list (scan of 2026-11-10).

The moving-average stack

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on XBI?

Uptrend stack intact — Trades +0.1% vs the 50-day and +8.8% vs the 200-day average, 8.7% below the 52-week high and +46.4% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is XBI above its 50-day and 200-day moving averages?

As of 2026-11-10, SPDR® S&P Biotech ETF trades +0.1% above its 50-day and +8.8% above its 200-day average, with the 20-day +1.6% away.

How far is XBI from its 52-week high?

8.7% below the 52-week high and 46.4% above the 52-week low, as of 2026-11-10.

Mentioned on Closelooknet

Where XBI appears in the diary — 1 piece, newest first. Every link is our own writing.

Long reads

  • Treasuries — Stock Market at a CrossroadsWeekly Signal · 17 May 2026Among the leading-indicator basket — KRE, XHB, IGV, XBI, IWM — the homebuilders ETF delivered the sharpest single message of the week.